Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma

Activating mutations involving the members of the RAS signaling pathway, including KRAS, NRAS, and BRAF, have been reported in ovarian low-grade serous carcinoma and its precursor lesion, serous borderline tumor (SBT). Whether additional genetic alterations in the RAS oncogene family accumulate duri...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hum Pathol
Egile Nagusiak: Xing, Deyin, Rahmanto, Yohan Suryo, Zeppernick, Felix, Hannibal, Charlotte G., Kjaer, Susanne K., Vang, Russell, Shih, Ie-Ming, Wang, Tian-Li
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696063/
https://ncbi.nlm.nih.gov/pubmed/28873354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2017.08.021
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak